XML 19 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Cash flows from operating activities:      
Net income (loss) $ (372,294) $ (669,244) $ 147,162
Adjustments to net income (loss):      
Depreciation and amortization 970,442 1,145,328 1,099,741
Accretion, depletion and other exploratory expenses 2,876 2,981 22,270
Deferred income tax expense (benefit) (203,145) (240,195) (103,277)
Deferred financing costs amortization 5,290 4,231 4,255
Discount amortization on long-term debt 1,969 3,131 2,137
Impairments and other charges 129,341 650,199 53,905
Loss on debt extinguishment   5,576 211,981
Losses (gains) on long-lived assets, net 63,338 353,110 18,060
Losses (gains) on investments, net   (5,580) (91,480)
Losses (gains) on other than temporary impairment 180,591    
Losses (gains) on merger and acquisitions 49,382    
Share-based compensation 47,313 37,190 53,255
Foreign currency transaction losses (gains), net 9,881 1,021 6,225
Equity in (earnings) losses of unconsolidated affiliates, net of dividends 84,275 7,102 800
Other 627 (762) (9,730)
Changes in operating assets and liabilities, net of effects from acquisitions:      
Accounts receivable 529,151 (126,883) (44,561)
Inventory 23,852 (65,398) 39,412
Other current assets 34,390 118,162 (6,943)
Other long-term assets (27,461) (30,475) 42,298
Trade accounts payable and accrued liabilities (566,042) 267,907 113,550
Income taxes payable (1,680) (57,113) (31,752)
Other long-term liabilities (6,776) 381,623 (109,085)
Net cash provided by operating activities 856,556 1,781,911 1,418,223
Cash flows from investing activities:      
Purchases of investments (9) (319)  
Sales and maturities of investments 961 23,992 164,510
Proceeds from sales of unconsolidated affiliates   750 12,640
Cash paid for acquisition of businesses, net (80,187) (72,534) (116,971)
Investments in unconsolidated affiliates (445) (2,365) (5,967)
Capital expenditures (867,106) (1,821,315) (1,178,205)
Proceeds from sales of assets and insurance claims 68,206 156,761 308,538
Proceeds from merger transaction 650,050    
Other Changes in Investing 1,081 (1,879) (13)
Net cash used for investing activities (227,449) (1,716,909) (815,468)
Cash flows from financing activities:      
Increase (decrease) in cash overdrafts 645 (6,151) (4,421)
Proceeds from issuance of long-term debt     698,753
Debt issuance costs (1,847)   (4,500)
Proceeds from revolving credit facilities   465,000  
Reduction in revolving credit facilities (450,000) (230,932) (720,000)
Proceeds from (payments for) issuance of common shares 1,296 30,263 5,383
Repurchase of common shares (99,598) (250,037)  
Purchase of preferred stock   (70,875)  
Reduction in long-term debt 27,478   994,181
Dividends to shareholders (69,363) (59,145) (47,168)
Proceeds from (payment for) commercial paper, net (525,119) 203,275 329,844
Proceeds from long term debt     698,753
Proceeds from Issuance of Debt 625,000    
Payments on term loan (300,000)    
Cash proceeds from noncontrolling Interest 3,972    
Other (7,449) (11,550) 6,704
Net cash (used for) provided by financing activities (849,941) 69,848 (729,586)
Effect of exchange rate changes on cash and cash equivalents (25,785) (23,616) (8,176)
Net increase (decrease) in cash and cash equivalents (246,619) 111,234 (135,007)
Cash and cash equivalents, beginning of period 501,149 389,915 524,922
Cash and cash equivalents, end of period $ 254,530 $ 501,149 $ 389,915